The World Health Summit 2026 Stipend & Fellowship Programme is offering a fully funded opportunity to attend the global health conference in Berlin, organizers said, with up to 15 participants to be selected through a competitive process.
The programme, supported by the Wellcome Trust, is aimed at individuals from low- and middle-income countries and people with lived experience who are actively contributing to improving health outcomes in their communities. Selected participants will attend the World Health Summit 2026 as delegates, not as speakers, and will have their travel and participation funded under the stipend and fellowship award.
Numbers give the effort its weight: only up to 15 people will be chosen to join the summit, which is scheduled for 11–13 October 2026 in Berlin. Shortlisted candidates will be contacted via email, the organisers say, and a waitlist may be used if any selected participants decline the offer.
Applications must be submitted through the official online platform, and the programme documentation notes that if the number of qualified applicants exceeds available slots, a lottery system may be applied to ensure fair selection and regional diversity. That combination of competitive screening and a potential lottery is intended to balance merit with an explicit push for inclusion.
Positioned as a way to broaden participation in global health dialogue, the stipend and fellowship aims to bring people who work directly on health problems into a forum described by the organisers as one of the most influential platforms for global health policy, research and collaboration. The organisers emphasize prioritizing individuals who are already contributing to improving health outcomes in their communities.
The friction in the plan is immediate and practical. Fifteen funded delegates for a major international summit will not come close to matching the scale of global demand; a lottery can make selection fairer when candidates outnumber slots, but it cannot increase capacity. And the distinction that recipients will attend as delegates, not speakers, underlines both the programme’s strength—funding attendance—and its limit: the fellowship does not guarantee a platform on the agenda.
That gap matters because access to the summit floor and to formal speaking slots is where policy influence is most visible. The stipend removes financial barriers to presence in Berlin, which can change who hears and who is heard in corridors and sessions. But without speaking roles or a follow-on commitment to amplify the delegates’ perspectives, attendance alone leaves questions about how much immediate influence the fellowship will deliver.
The application route is straightforward on paper: submit through the official online platform and await notice if shortlisted. Beyond that, the process includes contingencies intended to protect fairness—email contact for shortlisted candidates, a waitlist, and the possible use of a lottery to safeguard regional diversity when demand outpaces supply. Those rules mean the programme can be administered quickly and transparently; they also make clear the limits of what a single short programme can accomplish.
Viewed on balance, the stipend and fellowship is a pragmatic, targeted effort: it reduces a concrete barrier—cost of attendance—for a small number of practitioners and people with lived experience from lower‑ and middle‑income regions. But with only up to 15 slots available, the initiative is a modest step rather than a systemic fix. To change who shapes global health policy at scale would require sustained expansion of opportunities like this one, or mechanisms that turn delegate attendance into durable influence on research priorities and decisionmaking.
